CANCER SELECT

Brand Owner Address Description
CANCERSELECT Personal Genome Diagnostics Inc. 3600 Boston Street, Suite 10 Baltimore MD 21224 CANCER SELECT;Consulting and testing services in the field of genetic sequencing for medical, diagnostic and treatment purposes;Consulting, research, development, engineering and testing services in the field of genetic sequencing for scientific and laboratory purposes;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. This invention provides methods for detecting cancers and for evaluating the prognosis of cancer patients. In particular, the methods of this invention utilize YKL-40 as a marker for the presence or absence of a cancer and for the prognosis (e.g. likelihood of recurrence) of a cancer. Elevated levels of YKL-40 are indicative of the presence of a cancer in undiagnosed subjects and indicate likely recurrence of the cancer in subjects diagnosed as having a cancer.